Related Experiment Video
Updated: Dec 21, 2025
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
11.0K
COVID-19 Clinical trials: Quality matters more than quantity
Sergio Bonini1, Giuseppe Maltese2,3
1Institute of Translational Pharmacology, Italian National Research Council, Rome, Italy.
Allergy
|May 21, 2020
Summary
Despite numerous COVID-19 studies, safe and effective treatments remain elusive. Harmonized, large-scale clinical trials are crucial for identifying viable therapies against SARS-CoV-2.
Area of Science:
- Infectious Diseases
- Clinical Research Methodology
- Pharmacology
Background:
- The COVID-19 pandemic has spurred extensive research, yet evidence for safe and effective treatments lags behind the pandemic's rapid progression.
- Hundreds of clinical trials for candidate COVID-19 drugs are underway, but data accessibility and comparability are hindered by inconsistent information across registries.
Purpose of the Study:
- To highlight the challenges in COVID-19 drug development due to heterogeneous study designs and data sharing issues.
- To advocate for standardized, high-quality clinical trial methodologies to accelerate the identification of effective SARS-CoV-2 treatments.
Main Methods:
- Analysis of the current landscape of COVID-19 clinical trials and published literature.
- Identification of inconsistencies in study protocols, patient stratification, and outcome selection across different registries.
- Review of existing approaches to drug efficacy and safety evaluation.
Main Results:
- Significant heterogeneity exists in the design and reporting of COVID-19 clinical trials.
- Lack of standardized protocols and data sharing impedes secondary analyses and the synthesis of reliable evidence.
- Small, single-center studies and compassionate use of drugs are insufficient for establishing definitive treatment guidelines.
Conclusions:
- Highly powered, multi-center, multi-arm clinical trials are essential for generating robust evidence on the safety and efficacy of COVID-19 drugs.
- Harmonized guidelines and a collaborative commitment to data sharing are necessary to expedite the discovery of effective SARS-CoV-2 treatments.
- Allergists and clinical immunologists are positioned to play a key role in this global health challenge.
Related Concept Videos
01:16Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
01:11Clinical Trials: Overview
4.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.4K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
323
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
323
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
83
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
83
01:28Preclinical Development: Overview
5.6K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.6K
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
119
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
119